Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2008. Start Trial.
Date Value
September 30, 2026 98.50%
August 31, 2026 98.50%
July 31, 2026 98.50%
June 30, 2026 97.74%
May 31, 2026 96.82%
April 30, 2026 96.32%
March 31, 2026 95.87%
February 28, 2026 95.87%
January 31, 2026 95.87%
December 31, 2025 95.87%
November 30, 2025 95.87%
October 31, 2025 95.87%
September 30, 2025 96.27%
August 31, 2025 96.40%
July 31, 2025 96.40%
June 30, 2025 96.40%
May 31, 2025 96.78%
April 30, 2025 98.32%
March 31, 2025 98.32%
February 28, 2025 98.32%
January 31, 2025 98.32%
December 31, 2024 98.32%
November 30, 2024 98.32%
October 31, 2024 98.32%
September 30, 2024 98.32%
Date Value
August 31, 2024 98.32%
July 31, 2024 98.32%
June 30, 2024 98.32%
May 31, 2024 98.32%
April 30, 2024 98.32%
March 31, 2024 98.32%
February 29, 2024 98.32%
January 31, 2024 98.32%
December 31, 2023 98.32%
November 30, 2023 98.32%
October 31, 2023 98.32%
September 30, 2023 98.32%
August 31, 2023 98.32%
July 31, 2023 98.32%
June 30, 2023 98.32%
May 31, 2023 98.32%
April 30, 2023 98.32%
March 31, 2023 98.32%
February 28, 2023 98.32%
January 31, 2023 98.32%
December 31, 2022 98.32%
November 30, 2022 98.32%
October 31, 2022 98.32%
September 30, 2022 98.32%
August 31, 2022 98.32%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Cochlear Ltd. 71.44%
Nanosonics Ltd. 72.61%
Somnomed Ltd. 94.01%
Imagion Biosystems Ltd. 99.93%
Nova Eye Medical Ltd. 99.91%